Tague, L. K., Byers, D. E., Hachem, R., Kreisel, D., Krupnick, A. S., Kulkarni, H. S., . . . Gelman, A. (2019). Impact of SLCO1B3 Polymorphisms on Clinical Outcomes in Lung Allograft Recipients Receiving Mycophenolic Acid. Pharmacogenomics J.
Stile di citazione ChicagoTague, Laneshia K., Derek E. Byers, Ramsey Hachem, Daniel Kreisel, Alexander S. Krupnick, Hrishikesh S. Kulkarni, Catherine Chen, Howard J. Huang, e Andrew Gelman. "Impact of SLCO1B3 Polymorphisms On Clinical Outcomes in Lung Allograft Recipients Receiving Mycophenolic Acid." Pharmacogenomics J 2019.
Citazione MLATague, Laneshia K., et al. "Impact of SLCO1B3 Polymorphisms On Clinical Outcomes in Lung Allograft Recipients Receiving Mycophenolic Acid." Pharmacogenomics J 2019.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.